Researchers@EVMS
Toggle navigation
Browse
Home
People
Research Areas
Capability Map
Publications
Departments
Clinical Trials
Student Opportunities
FAQ
JOURNAL FOR IMMUNOTHERAPY OF CANCER
Journal
Overview
Identity
Other
View All
Overview
publication venue for
PHASE 2 TRIAL OF NEOADJUVANT AND ADJUVANT PD-1 CHECKPOINT BLOCKADE IN LOCAL-REGIONALLY ADVANCED, RESECTABLE HNSCC INDICATES PATHOLOGICAL RESPONSE IS ASSOCIATED WITH HIGH DISEASE-FREE SURVIVAL
2020
Identity
Electronic International Standard Serial Number (EISSN)
2051-1426
Other
journal abbreviation
J IMMUNOTHER CANCER